Ardent Health Partners (NYSE:ARDT - Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.730-2.010 for the period, compared to the consensus earnings per share estimate of 1.930. The company issued revenue guidance of $6.2 billion-$6.5 billion, compared to the consensus revenue estimate of $6.3 billion.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on the stock. Bank of America downgraded shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and cut their price target for the company from $22.00 to $19.00 in a report on Wednesday, November 6th. Morgan Stanley lowered their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research report on Tuesday, January 21st. Truist Financial lowered their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Royal Bank of Canada reiterated an "outperform" rating and set a $23.00 price objective on shares of Ardent Health Partners in a research note on Thursday, November 14th. Finally, Stephens reaffirmed an "overweight" rating and issued a $22.00 price target on shares of Ardent Health Partners in a report on Thursday. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $21.36.
Read Our Latest Research Report on ARDT
Ardent Health Partners Trading Down 3.3 %
Shares of NYSE:ARDT traded down $0.50 during midday trading on Friday, reaching $14.66. 726,478 shares of the company's stock were exchanged, compared to its average volume of 396,256. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The firm's 50 day simple moving average is $15.20 and its two-hundred day simple moving average is $16.83. Ardent Health Partners has a fifty-two week low of $13.55 and a fifty-two week high of $20.72.
Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion. On average, research analysts anticipate that Ardent Health Partners will post 1.23 earnings per share for the current year.
Ardent Health Partners Company Profile
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Read More
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.